| HGNC Family | Non-coding RNAs |
| Name | microRNA 939 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR-939 is emerging as a multifunctional regulator whose role spans diverse pathological settings, particularly in human cancers. In triple‐negative breast cancer, miR-939 is secreted via exosomes and directly targets VE-cadherin, thereby weakening endothelial cell–cell junctions and facilitating metastatic transit (via increased vascular permeability)."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In ovarian cancer, upregulation of miR-939 promotes cell proliferation and anchorage‐independent growth by directly suppressing the tumor suppressor APC2 and, in non–small cell lung cancer, miR-939 downregulation leads to a significant decline in proliferation and invasion via modulation of TIMP2."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "5"}]}, {"type": "t", "text": " Similarly, in glioma, increased levels of miR-939-5p correlate with enhanced proliferation, migration, and invasion through targeting TIMP2, collectively underscoring its context-dependent dual roles as both oncogene and tumor suppressor depending on the cancer type."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the cardiovascular and inflammatory arenas, miR-939 also plays a key regulatory role. In myocardial ischemia, exosomes from affected patients show significant downregulation of miR-939-5p, thereby releasing its inhibitory effect on inducible nitric oxide synthase (iNOS) and promoting angiogenesis and tissue repair."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " In vascular smooth muscle cells, reduced miR-939 levels are linked with a phenotypic shift that favors proliferation and migration through the de-repression of targets such as STIM1"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", while in hepatocytes, miR-939 targets the 3′-UTR of hiNOS to impose a translational blockade, ensuring a balanced nitric oxide output."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " Moreover, in inflammatory conditions including complex regional pain syndrome, downregulation of miR-939 corresponds with elevated proinflammatory mediator expression, further emphasizing its critical regulatory function. In coronary artery disease, overexpression of miR-939 in endothelial cells inhibits adhesion, proliferation, and tube formation by directly targeting γ-catenin, and in chronic heart failure, elevated serum miR-939-5p modulates cytokine-induced apoptosis in endothelial and myocardial cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncogenic and cardiovascular regulation, miR-939 is involved in diverse biological processes affecting host–pathogen interactions and cellular homeostasis. In chronic hepatitis B infection, miR-939 exerts antiviral activity by targeting host factor Jmjd3, which in turn alters the transcriptional activity of viral promoters."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " Its upregulation in Hirschsprung's disease is linked to reduced cell proliferation through targeting LRSAM1, while in neuronal cells, miR-939 directly suppresses the expression of the nerve growth factor receptor (NGFR), affecting cell survival pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " In kidney podocytes, miR-939 binds to promoter sequences of CD2AP, contributing to reduced expression of this slit diaphragm component and implicating it in podocyte injury."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": " Finally, preliminary investigations in the context of influenza virus infection have explored the impact of miR-939 on viral replication, further highlighting its versatile regulatory portfolio."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Martina Di Modica, Viola Regondi, Marco Sandri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2016.09.013"}], "href": "https://doi.org/10.1016/j.canlet.2016.09.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27693459"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27693459"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xiong Ying, Qi Li-ya, Zhou Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2015.02.020"}], "href": "https://doi.org/10.1016/j.biopha.2015.02.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25960217"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25960217"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Heba Nafea, Rana A Youness, Khaled Abou-Aisha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.30234"}], "href": "https://doi.org/10.1002/jcp.30234"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33368266"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33368266"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Wei Huo, Fei Qi, Kaichen Wang "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA BCYRN1 promotes prostate cancer progression via elevation of HDAC11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2020.7680"}], "href": "https://doi.org/10.3892/or.2020.7680"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32705287"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32705287"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Aidong Chen, Shengping Liu, Xiaohu Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of microRNA‑939 suppresses the development of human non‑small cell lung cancer via the upregulation of tissue inhibitor of metalloproteinases 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.9502"}], "href": "https://doi.org/10.3892/mmr.2018.9502"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30272338"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30272338"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Haitao Zheng, Hui Zhao, Gang Ye "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of microRNA-939-5p Contributes to Cell Proliferation and Associates Poor Prognosis in Glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromolecular Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12017-021-08655-1"}], "href": "https://doi.org/10.1007/s12017-021-08655-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33786745"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33786745"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jie Gao, Jun Chen, Xing Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_0058123 Targets the miR-939-5p/RAC1 Pathway to Promote the Development of Colorectal Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Genet (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10528-023-10485-8"}], "href": "https://doi.org/10.1007/s10528-023-10485-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37642813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37642813"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hao Li, Yiteng Liao, Lei Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Coronary Serum Exosomes Derived from Patients with Myocardial Ischemia Regulate Angiogenesis through the miR-939-mediated Nitric Oxide Signaling Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.21895"}], "href": "https://doi.org/10.7150/thno.21895"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29721064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29721064"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yan-Yang Mao, Jun-Qiang Wang, Xiao-Xian Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ-SATB2 upregulates STIM1 expression and regulates vascular smooth muscle cell proliferation and differentiation through miR-939."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.09.069"}], "href": "https://doi.org/10.1016/j.bbrc.2018.09.069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30241943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30241943"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zhong Guo, Lifang Shao, Liang Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1118118109"}], "href": "https://doi.org/10.1073/pnas.1118118109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22451906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22451906"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Marguerite K McDonald, Sujay Ramanathan, Andrew Touati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of proinflammatory genes by the circulating microRNA hsa-miR-939."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep30976"}], "href": "https://doi.org/10.1038/srep30976"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27498764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27498764"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Shiqiang Hou, Ming Fang, Qian Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-939 governs vascular integrity and angiogenesis through targeting γ-catenin in endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.01.085"}], "href": "https://doi.org/10.1016/j.bbrc.2017.01.085"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28115160"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28115160"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Cuncun Chen, Ming Zong, Ying Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differentially expressed lnc-NOS2P3-miR-939-5p axis in chronic heart failure inhibits myocardial and endothelial cells apoptosis via iNOS/TNFα pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15740"}], "href": "https://doi.org/10.1111/jcmm.15740"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32844595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32844595"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Cuncun Chen, Min Wu, Wen Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-939 restricts Hepatitis B virus by targeting Jmjd3-mediated and C/EBPα-coordinated chromatin remodeling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep35974"}], "href": "https://doi.org/10.1038/srep35974"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27779233"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27779233"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Guanglin Chen, Chunxia Du, Ziyang Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-939 inhibits cell proliferation via targeting LRSAM1 in Hirschsprung's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.101331"}], "href": "https://doi.org/10.18632/aging.101331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29253842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29253842"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Fahimeh Hosseini Aghdaei, Bahram M Soltani, Sadat Dokanehiifard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of hsa-miR-939 follows by NGFR down-regulation and apoptosis reduction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biosci (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12038-017-9669-6"}], "href": "https://doi.org/10.1007/s12038-017-9669-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28229962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28229962"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yu-Ping Huang, Ling-Zhi Qiu, Guo-Ping Zhou "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-939 down-regulates CD2-associated protein by targeting promoter in HEK-293T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ren Fail (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/0886022X.2016.1144443"}], "href": "https://doi.org/10.3109/0886022X.2016.1144443"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26895305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26895305"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "He Liu, Liping Song, Wenlin Huang "}, {"type": "b", "children": [{"type": "t", "text": "[MiR26a and miR939 regulate the replication of H1N1 influenza virus in MDCK cell]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Wei Sheng Wu Xue Bao (2010)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21141477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21141477"}]}]}]}
|
| Synonyms | MIRN939, HSA-MIR-939, MIR-939 |
| NCBI Gene ID | 100126351 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR939 has 646 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 18 datasets.
Click the + buttons to view associations for MIR939 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR939 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR939 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR939 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR939 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR939 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR939 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR939 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR939 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR939 from the GeneSigDB Published Gene Signatures dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR939 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MIR939 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR939 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR939 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MIR939 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR939 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR939 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR939 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| WikiPathways Pathways 2014 | pathways involving MIR939 protein from the Wikipathways Pathways 2014 dataset. | |